Relay Therapeutics Inc
(RLAY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 559,282 | 137,053 | 0 | N/A | 0 |
| Marketable Securities | 154,184 | 175,153 | 0 | N/A | 0 |
| TOTAL | $721,850 | $315,865 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 6,579 | 7,391 | N/A | N/A | N/A |
| Other Non-Current Assets | 23,252 | 24,779 | 0 | 0 | 0 |
| TOTAL | $29,831 | $32,170 | $N/A | $N/A | $N/A |
| Total Assets | $751,681 | $348,035 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,553 | 2,830 | 0 | 0 | 0 |
| Accrued Expenses | 9,680 | 8,565 | 0 | N/A | 0 |
| TOTAL | $15,666 | $12,765 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 22,490 | 560,662 | 0 | 0 | 0 |
| TOTAL | $22,490 | $560,662 | $N/A | $N/A | $N/A |
| Total Liabilities | $38,156 | $573,427 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 89,985 | 89,975 | N/A | N/A | N/A |
| Common Shares | 90 | 5 | 0 | N/A | 0 |
| Retained earnings | -439,504 | -241,092 | 0 | N/A | 0 |
| Other shareholders' equity | 176 | 631 | 0 | 0 | 0 |
| TOTAL | $713,525 | $-225,392 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $751,681 | $348,035 | $0 | $0 | $0 |